These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2143872)

  • 41. Suppression in class II MHC tolerance is mediated by Ia-specific lymphocytes that fail to mature into allodestructive effectors.
    Streilein JW; Mohler KM
    Transplant Proc; 1989 Feb; 21(1 Pt 1):236-7. PubMed ID: 2523129
    [No Abstract]   [Full Text] [Related]  

  • 42. Isolation of functional MHC class I-deficient islet cells.
    Osorio RW; Ascher NL; Jaenisch R; Natuzzi ES; Freise CE; Roberts JP; Stock PG
    Transplant Proc; 1993 Feb; 25(1 Pt 2):968-9. PubMed ID: 8442283
    [No Abstract]   [Full Text] [Related]  

  • 43. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fine specificity of class I MHC recognition in islet allografts.
    Ferguson D; Kohli N; Munn SR
    Transplant Proc; 1995 Dec; 27(6):3222. PubMed ID: 8539924
    [No Abstract]   [Full Text] [Related]  

  • 45. Marked differences between orthotopic and heterotopic auxiliary liver allografts in the induction of class II MHC antigens on hepatocytes.
    Icard P; Sawyer GJ; Houssin D; Fabre JW
    Transplant Proc; 1990 Aug; 22(4):1935. PubMed ID: 2117820
    [No Abstract]   [Full Text] [Related]  

  • 46. In vitro immunomodulation of human islet allografts using mixed islet lymphocyte coculture.
    Barrou B; Sylla C; Suberbielle C; Autran B; Debré P; Bitker MO
    Transplant Proc; 1997 Aug; 29(5):2396. PubMed ID: 9270777
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunogenetic considerations in islet transplantation: the role of Ia antigens in graft rejection.
    Bach FH; Morrow CE; Sutherland DE
    World J Surg; 1984 Apr; 8(2):204-6. PubMed ID: 6428060
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunological role of hepatic sinusoidal lining cells in swine liver transplantation.
    Inagaki M; Sakagami K; Orita K
    Transplant Proc; 1990 Aug; 22(4):1936-40. PubMed ID: 2143866
    [No Abstract]   [Full Text] [Related]  

  • 49. Lack of effect of cryopreservation on the class I and class II antigenicities of skin allografts.
    Tomita Y; Zhang QW; Yoshikawa M; Uchida T; Nomoto K; Yasui H
    Transplant Proc; 1998 Feb; 30(1):60-2. PubMed ID: 9474957
    [No Abstract]   [Full Text] [Related]  

  • 50. Primary and secondary autologous mixed-lymphocyte interactions in mice occur via antigens encoded by genes in the I region of the major histocompatibility complex.
    Bocchieri MH; Wolos JA; Smith JB
    Cell Immunol; 1981 Nov; 65(1):142-51. PubMed ID: 6459161
    [No Abstract]   [Full Text] [Related]  

  • 51. Production of H-2 class II (Ia.7) antibody is under Ir gene control.
    Hauptfeld-Dolejsek V; Shreffler DC
    Immunogenetics; 1989; 30(2):126-7. PubMed ID: 2503439
    [No Abstract]   [Full Text] [Related]  

  • 52. Pancreatic islet transplantation: immuno-alteration with ultraviolet irradiation.
    Hardy MA; Lau HT; Weber C; Reemtsma K
    World J Surg; 1984 Apr; 8(2):207-13. PubMed ID: 6428061
    [No Abstract]   [Full Text] [Related]  

  • 53. Identity of PL3A and SB1.
    Termijtelen A; Shaw S; van Rood JJ
    Tissue Antigens; 1983 May; 21(5):400-1. PubMed ID: 6223410
    [No Abstract]   [Full Text] [Related]  

  • 54. The role of HLA class II antigens/genes in xenogeneic iso, allo, and xeno transplantation.
    Tsuji K; Hagihara M; Sato T; Shimura T; Takebe K; Munkhbat B
    Transplant Proc; 1994 Aug; 26(4):2441-3. PubMed ID: 8066801
    [No Abstract]   [Full Text] [Related]  

  • 55. Prolongation of rat islet allografts with the use of ultraviolet irradiation, without immunosuppression.
    Hardy MA; Lau H; Reemtsma K
    Transplant Proc; 1984 Jun; 16(3):865-9. PubMed ID: 6233774
    [No Abstract]   [Full Text] [Related]  

  • 56. Manipulation of pancreatic islet cells in allotransplantation.
    Tze WJ; Tai J
    Transplant Proc; 1982 Dec; 14(4):714-23. PubMed ID: 6820204
    [No Abstract]   [Full Text] [Related]  

  • 57. Lack of tolerance to donor-strain skin grafts in mice with established islet allografts.
    Gores DF; Sutherland DE; Platt JL; Bach FH
    Transplantation; 1987 May; 43(5):749-50. PubMed ID: 2953095
    [No Abstract]   [Full Text] [Related]  

  • 58. Induced expression of class II major histocompatibility complex antigens on thyroid but not pancreatic islet allografts following transfer of sensitized LYT2+ T cells.
    Warren HS; Simeonovic CJ; Allan W; Hume DA
    Transplant Proc; 1987 Feb; 19(1 Pt 1):213. PubMed ID: 3152690
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunologic consequence of class II+ pancreatic islet allografts on recipient responsiveness.
    Markmann JF; Barker CF; Lo D; Brinster R; Heber-Katz E; Naji A
    Transplant Proc; 1990 Aug; 22(4):2052-3. PubMed ID: 2143872
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.